logo

WELGEST-H-250

No Rating No Ratings & NO Reviews

Composition

WELGEST-H-250


indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. Dosing Administer intramuscularly at a dose of 250 mg (1 mL) once weekly (every 7 days) by a healthcare provider Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first